Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants | Zendy

Kevin Hill | Zendy; Ewa Sucha | Zendy; Emily Rhodes | Zendy; Marc Carrier | Zendy; Amit X. Garg | Zendy; Ziv Harel | Zendy; Gregory L. Hundemer | Zendy; Edward G. Clark | Zendy; Greg Knoll | Zendy; Eric McArthur | Zendy; Manish M. Sood | Zendy

Open Access

Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants

Author(s) -

Kevin Hill,

Ewa Sucha,

Emily Rhodes,

Marc Carrier,

Amit X. Garg,

Ziv Harel,

Gregory L. Hundemer,

Edward G. Clark,

Greg Knoll,

Eric McArthur,

Manish M. Sood

Publication year - 2020

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2020.1835

Subject(s) - medicine , azithromycin , clarithromycin , apixaban , dabigatran , retrospective cohort study , rivaroxaban , population , cohort study , atrial fibrillation , antibiotics , warfarin , helicobacter pylori , microbiology and biotechnology , biology , environmental health

Clarithromycin is a commonly prescribed antibiotic associated with higher levels of direct oral anticoagulants (DOACs) in the blood, with the potential to increase the risk of hemorrhage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research